Skip to content

Where are you from?

Choose your province and we will tell you how the deputies and senators you elected vote, one by one.

 

We remember it in this browser. If you create an account, we keep it there.

Type a law, a topic, a person or a province.

What it is

Rules for using, releasing and selling genetically modified organisms

BOE step 7 of 7 · Passed

It is a government bill. Introduced by the Government. It was introduced on 5 August 2002. Introduced by: Gobierno.

Official title: Government bill establishing the legal regime for the contained use, voluntary release and marketing of genetically modified organisms.

Source: Congreso de los Diputados, file 121/000107· updated 11 Nov

Automatic summary, not yet reviewed

  1. The law regulates contained use, voluntary release and marketing of genetically modified organisms, to avoid risks to human health and the environment. It excludes humans from the definition of genetically modified organism.
  2. The autonomous communities authorize contained use and voluntary release, except in cases reserved to the State, such as medicines, State research or commercial plant varieties. The State always authorizes marketing, import and export.
  3. Contained use activities are classified by risk (negligible, low, moderate or high). Only moderate and high risk activities need express authorization; for the others, prior notification is generally enough.
  4. Any voluntary release into the environment requires prior authorization, with a technical study and a risk assessment including the methodology used. Marketing also requires authorization, valid for at most 10 years, with a monitoring plan, labeling and traceability.
  5. The law creates a fee for services of the State Administration, with charges ranging from €1,130 to €12,040 depending on the activity. There are 30% discounts and exemptions for public research projects.
  6. Offenses are classified as minor, serious or very serious, with fines of up to €1,200,000 and other penalties such as closing facilities. If the fine is lower than the profit obtained, it is increased to at least twice that profit.

Who it affects

  • Companies and individuals working with genetically modified organisms: They must assess risks, notify or request authorization, label, ensure traceability and pay the fee.
  • Autonomous communities: They authorize and monitor contained use and voluntary release, except in cases reserved to the State.
  • State Administration (Administración General del Estado): It authorizes marketing, import and export, and collects the fee.
  • Consumers: They receive information through labeling and public access to granted authorizations.

Words worth knowing

Utilización confinada (contained use)
An activity where a genetically modified organism is modified or used with measures that prevent its contact with people and the environment.
Liberación voluntaria (voluntary release)
Deliberately releasing genetically modified organisms into the environment, without containment measures.
Silencio administrativo desestimatorio (rejecting administrative silence)
If the Administration does not answer an authorization request in time, it is understood to have been denied.
Trazabilidad (traceability)
Keeping and passing on product data at every stage so its movements can be traced back and it can be withdrawn from the market if needed.
Autoliquidación (self-assessment)
The taxpayer calculates and pays the fee using official forms.

It summarizes the law as published in the BOE. It is written by artificial intelligence and may contain mistakes: the official text is what counts. Read the official text · How we make summaries

Where it stands

How far did it get?

It took 7 of 7 steps. It reached BOE, and today it is passed.

  1. Introduced5 August 2002Someone registers the text in the Congreso.
  2. Admitted13 August 2002The Bureau of the Congreso accepts it and, for a members’ bill, the plenary decides whether to consider it.
  3. Amendments20 August 2002Groups propose changes.
  4. Committee1 October 2002A committee goes through the text in detail.
  5. Plenary11 December 2002All 350 deputies vote.
  6. Senate19 December 2002The Senate can pass it, amend it or veto it.
  7. BOE3 April 2003It is published in the Official State Gazette (BOE) and comes into force.
See the 11 official steps on a timeline
Aug 2002Sept 2002Oct 2002Nov 2002Dec 2002Jan 2003Feb 2003Mar 200311. 5 August 2002: Presentación22. 13 August 2002: Comisión de Medio Ambiente Publicación desde 13/08/2002 hasta 20/08/200233. 13 August 2002: Calificación44. 20 August 2002: Comisión de Medio Ambiente Enmiendas desde 20/08/2002 hasta 11/10/200255. 1 October 2002: Comisión de Medio Ambiente Mesa - Calificación desde 01/10/2002 hasta 01/10/200266. 1 October 2002: Comisión de Medio Ambiente Debate de totalidad desde 01/10/2002 hasta 02/10/200277. 11 October 2002: Comisión de Medio Ambiente Informe desde 11/10/2002 hasta 26/11/200288. 26 November 2002: Comisión de Medio Ambiente Dictamen desde 26/11/2002 hasta 11/12/200299. 11 December 2002: Pleno Aprobación desde 11/12/2002 hasta 19/12/20021010. 19 December 2002: Senado desde 19/12/2002 hasta 03/04/20031111. 3 April 2003: Concluido - (Aprobado con modificaciones) desde 03/04/2003 hasta 27/05/2003

Was there a plenary vote?

We have no plenary vote linked to this law in the Congreso’s data.

What happens next

What happens now?

It is law, or will be once published in the BOE. It comes into force on the date its own text sets.

The same initiative in the other chamber:

Published in the BOE: Law 9/2003, of April 25, establishing the legal regime for the contained use, voluntary release, and marketing of genetically modified organisms.

Sources

Where does all this come from?

  • The data comes from the open files of the Congreso, the Senate and the BOE, unaltered.
  • Each deputy’s province is the one of their seat on the day of the vote.
  • We only say “passed” or “rejected” when the majority needed is certain; otherwise we say which side had more votes.